QUEBEC CITY, April 16 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc. (Victhom, TSX: VHB) today disclosed initial results from the ongoing human clinical trial of its Closed-Loop neuromodulation System (CLS) used in the Neurostep(TM) for the treatment of patients suffering from foot drop secondary to a central nervous system lesion. According to the Company, the initial results of the trial have demonstrated that the Neurostep(TM) is capable of collecting sensory signals from a nerve and of stimulating the appropriate muscle groups, which represents, to the knowledge of the Company, the world's first proof of concept in a human clinical trial of a CLS product used on peripheral nerves.
The ongoing human clinical trial on the Neurostep(TM) has two major objectives. The first objective is to evaluate the sensing and stimulation mechanisms of the product. The initial results suggest that the Neurostep(TM) is capable of collecting sensory signals from a nerve located in the thigh. The interim results also demonstrate the capacity of the Neurostep(TM), based on the information collected from the nerve, to stimulate the appropriate muscle group to lift the foot in the desired direction and in synchronization with the patient's gait.
The Company expects to announce later this year results on the second major objective of the trial aimed at evaluating the efficacy of the Neurostep (TM) in providing clinically measurable benefits, such as helping patients to walk faster and over longer distances.
Mr. Nader Kameli, Chief Operating Officer of the Neurobionix division,
said: "We are excited about the initial results coming out of the clinical
trial, which further increase our confidence in the ability of the
closed-loop technology to open the door to next generation products in the
neuromodulation industry that can deliver therapy to patients in a more
effective manner than the continuous or pre-programmed stimulation regimen
delivered by current
|SOURCE VICTHOM HUMAN BIONICS INC.|
Copyright©2008 PR Newswire.
All rights reserved